A137310 Stock Overview
An in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
SD Biosensor, Inc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩10,280.00 |
| 52 Week High | ₩15,340.00 |
| 52 Week Low | ₩7,870.00 |
| Beta | 0.85 |
| 1 Month Change | -6.63% |
| 3 Month Change | 11.98% |
| 1 Year Change | -10.14% |
| 3 Year Change | -81.10% |
| 5 Year Change | n/a |
| Change since IPO | -83.15% |
Recent News & Updates
Revenues Not Telling The Story For SD Biosensor, Inc (KRX:137310) After Shares Rise 29%
Dec 02
What SD Biosensor, Inc's (KRX:137310) 25% Share Price Gain Is Not Telling You
Aug 24Would SD Biosensor (KRX:137310) Be Better Off With Less Debt?
Aug 08Insufficient Growth At SD Biosensor, Inc (KRX:137310) Hampers Share Price
Jul 03Recent updates
Revenues Not Telling The Story For SD Biosensor, Inc (KRX:137310) After Shares Rise 29%
Dec 02What SD Biosensor, Inc's (KRX:137310) 25% Share Price Gain Is Not Telling You
Aug 24Would SD Biosensor (KRX:137310) Be Better Off With Less Debt?
Aug 08Insufficient Growth At SD Biosensor, Inc (KRX:137310) Hampers Share Price
Jul 03Insufficient Growth At SD Biosensor, Inc (KRX:137310) Hampers Share Price
Feb 28Shareholder Returns
| A137310 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -3.3% | 2.4% | -1.5% |
| 1Y | -10.1% | -1.9% | -12.2% |
Return vs Industry: A137310 underperformed the KR Medical Equipment industry which returned -4.3% over the past year.
Return vs Market: A137310 exceeded the KR Market which returned -12.2% over the past year.
Price Volatility
| A137310 volatility | |
|---|---|
| A137310 Average Weekly Movement | 6.3% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.8% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A137310 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A137310's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 576 | Hyo Keun Lee | www.sdbiosensor.com |
SD Biosensor, Inc, an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company’s products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decision making near-the-patient, which include analyzers, assay menus, qPCR reagents, and NA extraction kits; procell Dx, an in vitro diagnostic products for the diagnosis of infectious disease, such as tuberculosis and SARS-CoV-2, and for checking the immune status of individuals through the interferon gamma release assay; and blood glucose meters.
SD Biosensor, Inc Fundamentals Summary
| A137310 fundamental statistics | |
|---|---|
| Market cap | ₩1.26t |
| Earnings (TTM) | -₩63.22b |
| Revenue (TTM) | ₩674.07b |
1.9x
P/S Ratio-19.9x
P/E RatioIs A137310 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A137310 income statement (TTM) | |
|---|---|
| Revenue | ₩674.07b |
| Cost of Revenue | ₩352.29b |
| Gross Profit | ₩321.77b |
| Other Expenses | ₩384.99b |
| Earnings | -₩63.22b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -516.71 |
| Gross Margin | 47.74% |
| Net Profit Margin | -9.38% |
| Debt/Equity Ratio | 17.4% |
How did A137310 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 02:16 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
SD Biosensor, Inc is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Seung Taek Oh | Cape Investment & Securities Co., Ltd. |
| Song-hyup Han | Daishin Securities Co. Ltd. |
| Jonghyun Park | DAOL Investment & Securities Co., Ltd. |